I. Mikami et al., Down-regulation in multiple human cancers of a novel gene, DMHC, from 17q25.1 that encodes an integral membrane protein, JPN J CANC, 92(4), 2001, pp. 417-422
Frequent observations of allelic loss in chromosomal band 17q25.1 in a vari
ety of human cancers have suggested that one or more tumor suppressor genes
are present in that region. Moreover, a genetic locus for hereditary focal
non-epidermolytic palmoplantar keratoderma, a condition associated with ca
ncer of the esophagus (TOC; Tylosis with Oesophageal Cancer), lies in the s
ame region. We screened cell lines derived from a variety of human cancers
by reverse transcription-polymerase chain reaction (RT-PCR) to detect alter
ations in expression of genes within the region in question, by examining e
xpressed sequence tags located there. These experiments identified an 1834-
bp full-length cDNA encoding a novel, 441-amino acid integral membrane prot
ein with seven putative transmembrane domains. This gene showed loss or ext
reme decrease of expression in 6 of 10 uterine cancer-cell lines, 2 of 11 h
epatic cell carcinoma-cell lines, 2 of 7 lung cancer-cell lines, 1 of 6 gas
tric cancer-cell lines, and 1 of 10 breast cancer-cell lines. (We named it
DMHC ("down-regulated in multiple human cancers").) Our results suggest tha
t loss of expression of DMHC at 17q25.1 may play an important role in devel
opment of variety of human cancers.